Medicare Promoting Interoperability Program eCQM Requirements in CY 2023
The Centers for Medicare & Medicaid Services (CMS) would like to remind eligible hospitals and critical access hospitals (CAHs) participating in the Medicare Promoting Interoperability Program that they are required to report on a total of four electronic clinical quality measures (eCQMs) in calendar year (CY) 2023. This includes three self-selected eCQMs, plus the Safe Use of Opioids – Concurrent Prescribing measure.
As a reminder, when participants report on the four required eCQMs, they must submit a full year’s worth of data beginning with the reporting period in CY 2023. The table showcases all eCQMs available to report for CY 2023.
CY 2023 eCQM Names for Eligible Hospitals and CAHs
| Short Name | Measure Name |
| ED-2 | Median Admit Decision Time to ED Departure Time for Admitted Patients |
| HH-02 | Hospital Harm - Severe Hyperglycemia |
| HH-01 | Hospital Harm - Severe Hypoglycemia |
| PC-05 | Exclusive Breast Milk Feeding |
| STK-02 | Discharged on Antithrombotic Therapy |
| STK-03 | Anticoagulation Therapy for Atrial Fibrillation/Flutter |
| STK-05 | Antithrombotic Therapy by End of Hospital Day 2 |
| STK-06 | Discharged on Statin Medication |
| VTE-1 | Venous Thromboembolism Prophylaxis |
| VTE-2 | Intensive Care Unit Venous Thromboembolism Prophylaxis |
| Safe Use of Opioids | Safe Use of Opioids – Concurrent Prescribing |
| ePC-07/SMM | Severe Obstetric Complications* |
| ePC-02 | Cesarean Birth* |
*Voluntary for 2023
Additional Resources
For more information on the Medicare Promoting Interoperability Program, please visit the Promoting Interoperability Programs website. For further information regarding CY 2023 program requirements, please visit the Program Requirements webpage.